Peptidomimetic macrocycles
US-2017226177-A1 · Aug 10, 2017 · US
Peptidomimetic macrocycles and use thereof in regulating HIF1alpha
US10246491B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10246491-B2 |
| Application number | US-201514843079-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 2, 2015 |
| Priority date | Mar 6, 2013 |
| Publication date | Apr 2, 2019 |
| Grant date | Apr 2, 2019 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides peptidomimetic macrocycles capable of regulating HIF1α and methods of using such macrocycles for the treatment of diseases.
First claim
Opening claim text (preview).
What is claimed is: 1. A peptidomimetic macrocycle having the formula or a pharmaceutically acceptable salt thereof. 2. A peptidomimetic macrocycle having the formula or a pharmaceutically acceptable salt thereof. 3. A peptidomimetic macrocycle having the formula or a pharmaceutically acceptable salt thereof.
Assignees
Inventors
Classifications
Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00) · CPC title
- C07K7/56Primary
the cyclisation not occurring through 2,4-diamino-butanoic acid · CPC title
the modifying agent being an organic compound · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10246491B2 cover?
- The present invention provides peptidomimetic macrocycles capable of regulating HIF1α and methods of using such macrocycles for the treatment of diseases.
- Who is the assignee on this patent?
- Aileron Therapeutics Inc
- What technology area does this patent fall under?
- Primary CPC classification C07K7/56. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Apr 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).